Dr. Maia A. Rabaa, MHS, PhD
Maia Rabaa is a molecular epidemiologist and phylogeneticist at the Oxford University Clinical Research Unit (OUCRU) in Ho Chi Minh City, Vietnam, where she has been based since 2012. Maia conducts research to better understand the molecular evolution and epidemiology of a variety of pathogens.
Her work on viral pathogens includes studies of the evolution and phylogeography of flaviviruses (especially dengue and Zika) and Rotavirus A, the genetic epidemiology of the dengue virus in relation to vaccine efficacy, and the evolution and epidemiology of viruses at the human-animal interface. Her interests in evolutionary processes have also led her to more recently focus on the evolution and spread of antimicrobial resistance in populations across Asia, especially Shigella spp., E. coli, and Salmonella Typhi, and to design experimental work to uncover the evolutionary mechanisms that drive antimicrobial resistance.
More broadly, her research interests are in the design of disease surveillance, experimental methods, and analytical methods to optimize epidemiological and evolutionary inference and provide a strong scientific basis for public health decision-making, particularly as it relates to the establishment of sustainable, evolution-proof immunization and disease control programs.
Dr. Maia Rabaa has published over 40 articles in international journals. Key publications are highlighted below:
Chung The H, Boinett C, Duy PT, Jenkins C, Weill F-X, Howden BP, Valcanis M, De Lappe N, Cormican M, Wangchuk S, Bodhidatta L, Mason CJ, Nguyen TNT, Tuyen HT, Phat VV, Duong VT, Lan NPH, Turner P, Wick R, Ceyssens P-J, Thwaites GE, Holt KE, Thomson NR, Rabaa MA*,c, Baker S*. Dissecting the molecular evolution of fluoroquinolone-resistant Shigella sonnei. (2019) Nature Communications. 10:4828.
Rabaa MA, Girerd-Chambaz Y, Hue KDT, Tuan TV, Wills B, Bonaparte M, van der Vliet D, Langevin E, Cortes M, Zambrano B, Dunod C, Wartel-Tram A, Jackson N, Simmons CP. (2017) Genetic epidemiology of dengue virus populations in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy. eLife. 6:e24196.
Ho ZJM, Hapuarachchi HC, Barkham T, Chow A, Ng LC, Lee JMV, Leo YS, Prem K, Lim YHG, de Sessions PF, Rabaa MA, Chong CS, Tan CH, Rajarethinam J, Tan J, Anderson DE, Ong X, Cook AR, Chong CY, Hsu LY, Yap G, Lai YL, Chawla T, Pan L, Sim S, Chen IM, Thoon KC, Yung CF, Li JH, Ng HLD, Nandar K, Ooi PL, Lin RTP, Aw P, Uehara A, Pratim De P, Soon W, Hibberd ML, Ng HH, Maurer-Stroh S, Sessions OM. (2017) Outbreak of Zika in Singapore – an epidemiological, entomological, virological and clinical account. Lancet Infectious Diseases. 17(8):813-821.
The HC, Rabaa MA, Thanh DP, Delappe N, Cormican M, Valcanis M, Howden BP, Wangchuk S, Bodhidatta L, Mason CJ, Nguyen TNT, Thuy DV, Thompson CN, Nguyen PHL, Phat VV, Thanh TH, Turner P, Sar P, Thwaites G, Thomson NR, Holt KE, Baker S. (2016) South Asia as a reservoir for the global spread of ciprofloxacin resistant Shigella sonnei. PLoS Medicine. 13(8):e1002055.
Rabaa MA, Simmons CP, Fox A, Le MQ, Nguyen TTT, Le HY, Gibbons RV, Nguyen XT, Holmes EC, Aaskov JG. (2013) Dengue virus in sub-tropical northern and central Viet Nam: population immunity and climate shape patterns of viral invasion and maintenance. PLoS Neglected Tropical Disease. 7(12):e2581.
Google Scholar profile: https://scholar.google.com/citations?user=MMS75JMAAAAJ&hl=en